Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Adapt Ubiqare?s Specialty Care Platform to take care of COVID-19 patients during home quarantine and isolation ward stage | Sundararajan Srinivasan, Co-founder & CMD, ?Ubiqare Health Pvt Ltd, Bengaluru | 2020 | Specialty Care Platform for covid patients | |
| Small molecules screening on spike protein of Covid19 | Sivapriya Kirubakaran, Associate Professor, Vijay Thriuvenkatam, Assistant Research Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Pharmacodynamics |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
| Design of novel bactericidal molecules targeting a conserved bacterial transcription regulator | Dr Ranjan Sen, Scientist, Centre for DNA Fingerprinting and Diagnostics (CDFD), Telangana | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug design |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |
| Healthcare Technology Innovation Centre (HTIC)-Phase II | Dr. Mohanasankar Sivaprakasam, Associate Professor, Indian Institute of Technology (IIT), Chennai | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Adjuvant therapy |
| Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats | Prof Dharamvir Singh Arya, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Bristol-Myers Squibb (BMS) Company, USA | Pharmacology |
| Virtual National Oral Cancer Institute (VNOCI) | Dr. Kodaganur S Gopinath, Surgical Oncologist, Bengaluru Institute Of Oncology, Prof. Saumyadipta Pyne, Scientific Director, Indian Institute of Public Health (IIPH), Hyderabad, Dr. Annapoorni Rangarajan, Assistant Professor, Indian Institute of Science (IISc), Bengaluru, Dr. Ramaswamy Subramanian, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Prof. Tapas K Kundu,Professor, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, Dr. Birendranath Banerjee, Associate Professor, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Dr. Rekha V Kumar, Professor, Kidwai Memorial Institute of Oncology (KMIO), Bengaluru, Prof. Partha Pratim Majumder, Professor, National Institute of Biomedical Genomics (NIBG), Kalyani Dr. Anupam Chatterjee, Professor, North-Eastern Hill University (NEHU), Shillong, Dr. Tessy Thomas Maliekal, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |